Added Value of OCT for Diagnosing Recurrent BCC After Non-invasive Treatment (TOBI)

Maastricht University Medical Centre (MUMC)

Status: Completed

Conditions: Basal Cell Carcinoma

Treatments: Diagnostic Test: Punch biopsy (3mm)

Study type: Interventional

Funder types: Other

Identifiers

NCT05581342

NL74245.068.20

Details and patient eligibility

About

Superficial basal cell carcinoma (sBCC) can be treated non-invasively, but follow-up is necessary because lesions can reoccur. This study aims to evaluate the additional value of optical coherence tomography (OCT) for the detection of recurrent BCC lesions, that may remain unrecognized by clinical and dermoscopic examination (CDE). This study compared the diagnostic accuracy of CDE and CDE combined with OCT for detection of recurrent basal cell carcinoma (BCC) after non-invasive treatment of sBCC.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Non-invasively treated sBCC patients
• 18+ years of age

Exclusion criteria

• Unable to sign informed consent

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: Single Blind